El Khoury AC - Search Results

1

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis.

Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ. Cooper CL, et al. Among authors: el khoury ac. Ther Clin Risk Manag. 2012;8:105-30. doi: 10.2147/TCRM.S29830. Epub 2012 Mar 9. Ther Clin Risk Manag. 2012. PMID: 22442631 Free PMC article.

2

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis.

Cooper C, Lester R, Thorlund K, Druyts E, El Khoury AC, Yaya S, Mills EJ. Cooper C, et al. Among authors: el khoury ac. QJM. 2013 Feb;106(2):153-63. doi: 10.1093/qjmed/hcs214. Epub 2012 Nov 17. QJM. 2013. PMID: 23159839 Free PMC article.

3

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection.

Thorlund K, Druyts E, El Khoury AC, Mills EJ. Thorlund K, et al. Among authors: el khoury ac. Clinicoecon Outcomes Res. 2012;4:349-59. doi: 10.2147/CEOR.S37205. Epub 2012 Nov 16. Clinicoecon Outcomes Res. 2012. PMID: 23180971 Free PMC article.

4

Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal.

Elbasha EH, Chhatwal J, Ferrante SA, El Khoury AC, Laires PA. Elbasha EH, et al. Among authors: el khoury ac. Appl Health Econ Health Policy. 2013 Feb;11(1):65-78. doi: 10.1007/s40258-012-0007-8. Appl Health Econ Health Policy. 2013. PMID: 23355388

5

Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.

Chhatwal J, Ferrante SA, Brass C, El Khoury AC, Burroughs M, Bacon B, Esteban-Mur R, Elbasha EH. Chhatwal J, et al. Among authors: el khoury ac. Value Health. 2013 Sep-Oct;16(6):973-86. doi: 10.1016/j.jval.2013.07.006. Value Health. 2013. PMID: 24041347 Free PMC article.

6

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

Ferrante SA, Chhatwal J, Brass CA, El Khoury AC, Poordad F, Bronowicki JP, Elbasha EH. Ferrante SA, et al. Among authors: el khoury ac. BMC Infect Dis. 2013 Apr 27;13:190. doi: 10.1186/1471-2334-13-190. BMC Infect Dis. 2013. PMID: 23621902 Free PMC article. Clinical Trial.

7

Chronic hepatitis C virus (HCV) disease burden and cost in the United States.

Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, Kumar R. Razavi H, et al. Hepatology. 2013 Jun;57(6):2164-70. doi: 10.1002/hep.26218. Epub 2013 May 6. Hepatology. 2013. PMID: 23280550 Free PMC article.

8

Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.

Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR. Itzler RF, et al. Among authors: el khoury ac. J Med Econ. 2011;14(6):748-58. doi: 10.3111/13696998.2011.614303. Epub 2011 Sep 15. J Med Econ. 2011. PMID: 21919673 Free article.

9

Health-related quality of life in patients with hepatitis C virus infection in Brazil.

El Khoury AC, Vietri J, Prajapati G. El Khoury AC, et al. Rev Panam Salud Publica. 2014 Mar;35(3):200-6. Rev Panam Salud Publica. 2014. PMID: 24793867

10

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas.

El Khoury AC, Wallace C, Klimack WK, Razavi H. El Khoury AC, et al. J Med Econ. 2012;15(5):887-96. doi: 10.3111/13696998.2012.681332. Epub 2012 May 24. J Med Econ. 2012. PMID: 22458755 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters